MedPath

Combined chemotherapy with decetaxel and nedaplatin for advanced esophageal cancer, phaseI/II study.

Not Applicable
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000002037
Lead Sponsor
Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

double cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of effectiveness after therapy
Secondary Outcome Measures
NameTimeMethod
Evaluation of safety after therapy
© Copyright 2025. All Rights Reserved by MedPath